PSYC FPX 4310 Assessment 1 Analysis Of Articles

PSYC-FPX4310

Prof. Name

December, 2024

Introduction

PSYC FPX 4310 assessment 1 The neurobiology of MDMA abuse is one of the most essential research fields in biological psychology (Valentino et al., 2023). This is because the drug has been widely accepted in recreational life and has profound effects on the brain. MDMA is a psychoactive drug, which influences mood, perception, and social relationships; thus, it has gained wide use but remains dangerous. Its neurochemical implications in the brain’s serotonergic system and its long-term cognitive-emotional impact on the person involved have drawn a lot of interest among scientists. Knowing the neurobiological mechanisms of MDMA abuse may lead to better strategies for intervention and treatment.

To discuss this subject, I employed a systematic search strategy to identify peer-reviewed journal articles relevant to this subject. Keywords were “MDMA,” “ecstasy,” “neurobiology,” “serotonin,” “drug abuse,” and “cognitive impairment.” The articles published within the last ten years were searched using PsycINFO, PubMed, and ScienceDirect databases since they contain the most comprehensive research related to psychology and neuroscience. The following selected articles are therefore highly fundamental for the extensive knowledge regarding the neurobiological implications of MDMA on both the short-term and long-term bases within behavioral functions, brain processes, and mental conditions.

MDMA abuse is an area of research that holds significant ethical and health-related implications (Stubbs & Szoeke, 2021). The fact that the drug is popular among young adults and is often characterized as a “party drug” overshadows the severe neurotoxic effects it can cause. Research on this topic also contributes to the general debates on drug policy, harm reduction strategies, and public health education. This paper aims to analyze the methodologies and findings of the major research studies on MDMA to evaluate their contribution to the field of biological psychology.

Article Analysis

Montgomery, C., & Roberts, C. A. (2020). The neurobiological mechanisms underpinning MDMA and impaired psychological functioning. Psychobiological Issues in Substance Use and Misuse, 92–104. https://doi.org/10.4324/9780429296345-5

Montgomery & Roberts (2020) explored the neurobiological mechanisms through which MDMA, popularly known as ecstasy, affects psychological functioning. Their research focuses on MDMA’s influence on neurotransmitter systems, especially serotonin and dopamine, that are responsible for mood regulation, cognition, and behavior. The authors point out how MDMA encourages excessive release of serotonin, which is associated with acute euphoria and emotional connection but also contributes to long-term serotonergic neurotoxicity. This neurotoxicity has been associated with impairments in memory, executive functioning, and emotional regulation. Such findings underscore the importance of the current study to provide evidence for the more generalized psychological and neurological effects of MDMA, furthering our understanding of how it might compromise mental health and cognitive resilience.

The authors adopt a multidisciplinary approach combining the results of neuroimaging studies, biochemical assays, and clinical trials in drawing out a comprehensive profile for MDMA mechanisms of action. The paper also underlines the ethical issues, especially concerning human studies, with potential neurotoxic risks weighing against research benefits. The article further discusses possible therapeutic applications of MDMA in controlled settings, such as psychotherapy for PTSD, but advises against the use of the substance recreationally due to the associated risks. Montgomery & Roberts (2020) conclude by calling for further longitudinal research to uncover the long-term effects of MDMA and ensure its proper application in clinical settings.

Lyubomirsky, S. (2022). Toward a new science of psychedelic social psychology: The effects of MDMA (Ecstasy) on social connection. Perspectives on Psychological Science17(5), 174569162110553. https://doi.org/10.1177/17456916211055369

Lyubomirsky (2022) writes about the psychological and social effects of MDMA, placing special emphasis on its application in enhancing social connection and increasing empathy. The article talks about the neurobiological basis of these effects; and how MDMA increases oxytocin and serotonin levels, which contribute to trust, closeness, and feelings of emotional bonding. In this regard, these properties have sparked some interest in the therapeutic applications of MDMA, especially in the treatment of social anxiety and emotional openness during psychotherapy. In the book, the author goes ahead to talk about what this finding entails concerning human social behaviors and the neurochemical basis of social connection.

It’s conducted on the grounds of well-tested methodologies, including clinical trials and neuroimaging studies, to test the influence of MDMA on social cognition and interpersonal relationships. An ethical concern remains paramount regarding controlled therapeutic administrations of MDMA compared to uncontrolled recreational usage. Further, Lyubomirsky (2022) recommends that future studies examine how MDMA influences social functioning long-term for individuals with psychological vulnerabilities. This work significantly adds to the expanding literature on psychedelics and their contribution to informing not only the practices of therapy but broader theories of social psychology as well.

Rizzo, F. R., Bruno, A., Federici, M., & Mercuri, N. B. (2022). 3,4-Methylenedioxymethamphetamine (MDMA) and synaptic dopamine. Springer EBooks, 1–19. https://doi.org/10.1007/978-3-030-67928-6_116-1

Rizzo et al. (2022) examine the impact of MDMA on synaptic dopamine, describing in detail the neurochemical mechanisms triggered by its use. In this regard, the release of dopamine by MDMA stimulation in the brain’s reward pathways leads to heightened pleasure and reinforcement of drug-seeking behavior. This dopaminergic activity is believed to be a critical factor involved in the addictive potential of MDMA and its capacity for disrupting normal synaptic functioning. The authors also discuss neuroadaptive changes in dopamine transmission that occur due to protracted exposure to MDMA that may lead to long-lasting impairments in cognitive and motor performance.

The study utilizes highly sophisticated methodologies, such as electrophysiological recordings and neuroimaging, to research the effects. The authors of the paper critically address ethical concerns about using MDMA in research areas that include risks from neurotoxicity as well as addiction when subjects involved are human. Thus, they advocate for stringent safety protocols to minimize harm even while expanding our understanding of the impact of MDMA on dopamine systems. Rizzo et al. (2022) emphasize the relevance of their results to the formulation of public health policies and debates on the therapeutic versus the recreational use of MDMA. This article significantly contributes to the discussion about the complex effects of MDMA on brain chemistry and behavior.

Erritzoe, D., Godlewska, B. R., Rizzo, G., Searle, G. E., Agnorelli, C., Lewis, Y., Ashok, A. H., Colasanti, A., Boura, I., Farrell, C., Parfit, H., Howes, O., Passchier, J., Gunn, R. N., Nutt, D. J., Cowen, P. J., Knudsen, G., & Rabiner, E. A. (2022). Brain serotonin release is reduced in patients with depression: A [11c]Cimbi-36 PET study with a D-amphetamine challenge. Biological Psychiatry93(12). https://doi.org/10.1016/j.biopsych.2022.10.012

Erritzoe et al. (2022) looked into the role of the release of brain serotonin in patients with depression, making use of advanced neuroimaging techniques combined with a d-amphetamine challenge. The study showed that the release of serotonin is highly reduced among depressed patients and thus provides insight into the neurobiological underpinnings of mood disorders. While not a direct examination of MDMA, the general findings hold significance for studying the potential of MDMA because it targets the serotonergic pathways that induce both mood elevation and emotional opening. Further, the severity of symptoms associated with major depression corresponds with the inability to enhance serotonin release as well. It has elucidated a critical piece of mental health through an understanding of neurotransmitter dysregulation.

Using the tool of [11C]Cimbi-36 PET imaging, such novel measurements of serotonin receptor occupancy present new methods for assessing neurotransmitter dynamics. Ethical use has also been considered, especially regarding amphetamine administration and the use of imaging agents on subjects in vulnerable populations. Findings are important from the standpoint of understanding mechanisms for depression and potential therapy; however, the use of serotonergic-based interventions like MDMA is highly discouraged until further research occurs. In alluding to the important function played by serotonin in regulating moods, this article expands the general discourse surrounding the role played by MDMA in influencing serotonergic systems.

Haug, N. A., Richa Wadekar, Barry, R., & Sottile, J. E. (2023). Risk for ecstasy use disorder and other substance use among international users of recreational ECSTASY/MOLLY/MDMA. Journal of Psychoactive Drugs, 1–10. https://doi.org/10.1080/02791072.2023.2227960

This is an examination of the risk factors associated with ecstasy, or MDMA use disorder, and other substance use among international recreational users, conducted by Haug et al. (2023). It points to several behavioral, psychological, and demographic factors that indicate an increased probability of acquiring substance use disorders. Specifically, the psychoactive properties of MDMA-elicited effects of enhanced emotional openness and sensory enhancement encourage recreational consumption, leading to eventual dependency. The study also explores the co-use of MDMA with other substances, focusing on how this polysubstance use complicates the treatment outcome and increases health risks.

It gathers information about a diverse international sample based on a survey methodology to illustrate global patterns of recreational use of MDMA. It covers issues such as participant anonymity and informed consent to raise ethical considerations in gathering information. Haug et al. (2023) suggest targeted public health interventions to reduce the danger of MDMA abuse by educating the public about uncontrolled drug use and strategies for harm reduction. This article will contribute to a broader understanding of the risks of MDMA and reinforce the importance of balancing its recreational and therapeutic use with evidence-based safety measures.

PSYC FPX 4310 assessment 1 Conclusion

In summary, the above-analyzed articles all point towards a very complex interplay of neurobiological mechanisms with MDMA, its potential as a therapy, and associated risks. From its impacts on dopamine and serotonin systems to its implications for the treatment of mental health disorders and the understanding of substance use behaviors, the studies point out some multifaceted effects of MDMA (Papaseit et al., 2022). Nonetheless, they underscore the need to take ethical considerations and safe practices into both recreational and therapeutic applications, stressing continued study to understand and responsibly capitalize on the potential of MDMA.

PSYC FPX 4310 assessment 1 References

Erritzoe, D., Godlewska, B. R., Rizzo, G., Searle, G. E., Agnorelli, C., Lewis, Y., Ashok, A. H., Colasanti, A., Boura, I., Farrell, C., Parfit, H., Howes, O., Passchier, J., Gunn, R. N., Nutt, D. J., Cowen, P. J., Knudsen, G., & Rabiner, E. A. (2022). Brain serotonin release is reduced in patients with depression: A [11c]Cimbi-36 PET study with a D-amphetamine challenge. Biological Psychiatry93(12). https://doi.org/10.1016/j.biopsych.2022.10.012

Haug, N. A., Richa Wadekar, Barry, R., & Sottile, J. E. (2023). Risk for ecstasy use disorder and other substance use among international users of recreational ECSTASY/MOLLY/MDMA. Journal of Psychoactive Drugs, 1–10. https://doi.org/10.1080/02791072.2023.2227960

Lyubomirsky, S. (2022). Toward a new science of psychedelic social psychology: The effects of MDMA (Ecstasy) on social connection. Perspectives on Psychological Science17(5), 174569162110553. https://doi.org/10.1177/17456916211055369

Montgomery, C., & Roberts, C. A. (2020). The neurobiological mechanisms underpinning MDMA and impaired psychological functioning. Psychobiological Issues in Substance Use and Misuse, 92–104. https://doi.org/10.4324/9780429296345-5

Papaseit, E., Magí Farré, & Pérez-Mañá, C. (2022). Drug and MDMA interactions implications for public health. Springer EBooks, 1–26. https://doi.org/10.1007/978-3-030-67928-6_121-1